CYB5R4 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.923700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.262300E-02
Normal-vs-Stage2
3.624400E-03
Normal-vs-Stage3
1.874380E-02
Normal-vs-Stage4
4.572600E-01
Stage1-vs-Stage2
9.274800E-01
Stage1-vs-Stage3
3.262800E-01
Stage1-vs-Stage4
2.445000E-01
Stage2-vs-Stage3
2.630600E-01
Stage2-vs-Stage4
6.275800E-02
Stage3-vs-Stage4
1.045970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.840500E-03
Normal-vs-AfricanAmerican
1.208410E-01
Normal-vs-Asian
9.277400E-03
Caucasian-vs-AfricanAmerican
5.293600E-01
Caucasian-vs-Asian
2.238600E-01
AfricanAmerican-vs-Asian
2.678800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.441200E-03
Normal-vs-Female
9.920200E-03
Male-vs-Female
2.378200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.384400E-02
Normal-vs-Age(41-60Yrs)
8.897800E-03
Normal-vs-Age(61-80Yrs)
4.935700E-03
Normal-vs-Age(81-100Yrs)
4.881300E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.000200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.227000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.401000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.122630E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.062200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.034400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.417800E-04
Normal-vs-Daily Drinker
3.612100E-04
Normal-vs-Weekly Drinker
3.543800E-02
Normal-vs-Occasional Drinker
5.103600E-02
Normal-vs-Social Drinker
3.960300E-02
Non Drinker-vs-Daily Drinker
4.766000E-01
Non Drinker-vs-Weekly Drinker
5.033000E-01
Non Drinker-vs-Occasional Drinker
2.265600E-01
Non Drinker-vs-Social Drinker
3.199200E-01
Daily Drinker-vs-Weekly Drinker
2.653200E-01
Daily Drinker-vs-Occasional Drinker
1.070780E-01
Daily Drinker-vs-Social Drinker
1.540590E-01
Weekly Drinker-vs-Occasional Drinker
7.210200E-01
Weekly Drinker-vs-Social Drinker
8.311000E-01
Occasional Drinker-vs-Social Drinker
8.848000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.974400E-01
Normal-vs-Grade 2
8.293200E-01
Normal-vs-Grade 3
8.849400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.368200E-01
Grade 1-vs-Grade 3
9.798800E-01
Grade 1-vs-Grade 4
6.974400E-01
Grade 2-vs-Grade 3
3.245000E-01
Grade 2-vs-Grade 4
8.293200E-01
Grade 3-vs-Grade 4
8.849400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.541800E-03
Normal-vs-NonDiabetic
1.283240E-03
Diabetic-vs-NonDiabetic
7.560400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.629700E-04
Normal-vs-NoPancreatitis
3.324300E-03
Pancreatitis-vs-NoPancreatitis
1.534770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.839000E-03
Normal-vs-N1
4.420900E-03
N0-vs-N1
8.617200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.318400E-03
Normal-vs-TP53-NonMutant
2.029600E-02
TP53-Mutant-vs-TP53-NonMutant
4.937200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
